Study of hepatitis e virus infection of genotype 1. and 3 in mice with humanised liver

Gut

Volumn 66, Issue 5, 2016, Pages 920-929

  Sayed, Ibrahim M ^a,b   Verhoye, Lieven ^a   Cocquerel, Laurence ^c   Abravanel, Florence ^d,e   Foquet, Lander ^a   Montpellier, Claire ^c   Debing, Yannick ^f   Farhoudi, Ali ^a   Wychowski, Czeslaw ^c   Dubuisson, Jean ^c   Leroux Roels, Geert ^a   Neyts, Johan ^f   Izopet, Jacques ^d,e   Michiels, Thomas ^g   Meuleman, Philip ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Assiut University Faculty of Medicine   (Egypt)

^c UNIV LILLE   (France)

^d CHU PURPAN   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^g DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HUMAN ALBUMIN; RIBAVIRIN; VIRAL PROTEIN; VIRUS RNA; ANTIVIRUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DENSITY GRADIENT; DRUG DOSE ESCALATION; FECES ANALYSIS; GENE EXPRESSION; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 1; HEPATITIS E VIRUS GENOTYPE 2; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; LIVER TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA ANALYSIS; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS PARTICLE; ANIMAL; CHEMISTRY; DISEASE MODEL; GENETICS; GENOTYPE; HISTOCOMPATIBILITY; HOST PATHOGEN INTERACTION; LIVER; LIVER CELL; TRANSPLANTATION; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER; MICE; RIBAVIRIN; RNA, VIRAL; TRANSPLANTATION CHIMERA; VIRAL LOAD; VIRAL PROTEINS;

EID: 84962835809     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-311109     Document Type: Article

References (41)

1. Sayed IM, Vercouter AS, Abdelwahab SF, et al. Is hepatitis E virus an emerging problem in industrialized countries? Hepatology 2015;62:1883-92.
2. Holla RP, Ahmad I, Ahmad Z, et al. Molecular virology of hepatitis E virus. Semin Liver Dis 2013;33:3-14.
3. Sayed IM, Vercauteren K, Abdelwahab SF, et al. The emergence of hepatitis E virus in Europe. Future Virol 2015;10:763-78.
4. Hewitt PE, Ijaz S, Brailsford SR, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014;384:1766-73.
5. Debing Y, Gisa A, Dallmeier K, et al. A Mutation in the Hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology 2014;147:1008-11.e7; quiz e15-16.
6. Shukla P, Nguyen HT, Torian U, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci U S A 2011;108:2438-43.
7. Okamoto H. Hepatitis E virus cell culture models. Virus Res 2011;161:65-77.
8. Nguyen HT, Shukla P, Torian U, et al. Hepatitis E virus genotype 1 infection of swine kidney cells in vitro is inhibited at multiple levels. J Virol 2014;88:868-77.
9. Emerson SU, Zhang M, Meng XJ, et al. Recombinant hepatitis E virus genomes infectious for primates: Importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci U S A 2001;98:15270-5.
10. Purcell RH, Engle RE, Govindarajan S, et al. Pathobiology of hepatitis E: lessons learned from primate models. Emerg Microbes Infect 2013;2:e9.
11. Sanford BJ, Dryman BA, Huang YW, et al. Prior infection of pigs with a genotype 3 swine hepatitis E virus (HEV) protects against subsequent challenges with homologous and heterologous genotypes 3 and 4 human HEV. Virus Res 2011;159:17-22.
12. Feagins AR, Opriessnig T, Huang YW, et al. Cross-species infection of specific-pathogen-free pigs by a genotype 4 strain of human hepatitis E virus. J Med Virol 2008;80:1379-86.
13. Meuleman P, Libbrecht L, De Vos R, et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 2005;41:847-56.
14. Foquet L, Hermsen CC, van Gemert GJ, et al. Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice. Malar J 2013;12:430.
15. Vercauteren K, de Jong YP, Meuleman P. HCV animal models and liver disease. J Hepatol 2014;61(1 Suppl):S26-33.
16. Vercauteren K, de Jong YP, Meuleman P. Animal models for the study of HCV. Curr Opin Virol 2015;13:67-74.
17. Meuleman P, Vanlandschoot P, Leroux-Roels G. A simple and rapid method to determine the zygosity of uPA-transgenic SCID mice. Biochem Biophys Res Commun 2003;308:375-8.
18. Vanwolleghem T, Libbrecht L, Hansen BE, et al. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice. J Hepatol 2010;53:468-76.
19. Jothikumar N, Cromeans TL, Robertson BH, et al. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006;131:65-71.
20. Baylis SA, Blümel J, Mizusawa S, et al. World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Emerg Infect Dis 2013;19:729-35.
21. Okamoto H. Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood. Rev Med Virol 2011;21:18-31.
22. Yamada K, Takahashi M, Hoshino Y, et al. ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J Gen Virol 2009;90(Pt 8):1880-91.
23. Takahashi M, Tanaka T, Takahashi H, et al. Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol 2010;48:1112-25.
24. Okamoto H. Culture systems for hepatitis E virus. J Gastroenterol 2013;48:147-58.
25. Li X, Kamili S, Krawczynski K. Quantitative detection of hepatitis E virus RNA and dynamics of viral replication in experimental infection. J Viral Hepat 2006;13:835-9.
26. Tsarev SA, Tsareva TS, Emerson SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 1994;91:10198-202.
27. Williams TP, Kasorndorkbua C, Halbur PG, et al. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J Clin Microbiol 2001;39:3040-6.
28. Chalupa P, Vasickova P, Pavlik I, et al. Endemic hepatitis E in the Czech Republic. Clin Infect Dis 2014;58:509-16.
29. Christensen PB, Engle RE, Hjort C, et al. Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin Infect Dis 2008;47:1026-31.
30. Kamar N, Dalton HR, Abravanel F, et al. Hepatitis E virus infection. Clin Microbiol Rev 2014;27:116-38.
31. Abravanel F, Lhomme S, Chapuy-Regaud S, et al. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J Infect Dis 2014;209:1900-6.
32. Tsarev SA, Tsareva TS, Emerson SU, et al. Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J Med Virol 1994;43:135-42.
33. Kasorndorkbua C, Guenette DK, Huang FF, et al. Routes of Transmission of Swine Hepatitis E Virus in Pigs. J Clin Microbiol 2004;42:5047-52.
34. Kasorndorkbua C, Halbur PG, Thomas PJ, et al. Use of a swine bioassay and a RT-PCR assay to assess the risk of transmission of swine hepatitis E virus in pigs. J Virol Methods 2002;101:71-8.
35. Yu C, Boon D, McDonald SL, et al. Pathogenesis of hepatitis E virus and hepatitis C virus in chimpanzees: similarities and differences. J Virol 2010;84:11264-78.
36. Wedemeyer H, Rybczynska J, Pischke S, et al. Immunopathogenesis of hepatitis E virus infection. Semin Liver Dis 2013;33:71-8.
37. Geng Y, Zhao C, Huang W, et al. Detection and assessment of infectivity of hepatitis E virus in urine. J Hepatol 2016;64:37-43.
38. Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med 2014;370:1111-20.
39. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481-9.
40. Abravanel F, Lhomme S, Rostaing L, et al. Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. Clin Infect Dis 2015;60:96-9.
41. Ambrosioni J, Mamin A, Hadengue A, et al. Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin. Clin Microbiol Infect 2014;20:O718-O20.